INTRODUCTION
In mammalian cells, numerous membrane-bound receptors are coupled to phospholipase C, via a regulatory G-protein, which upon activation hydrolyses the plasma-membrane phospholipid phosphatidylinositol 4,5-biphosphate (PtdInsP2), producing the two second messengers inositol 1,4,5-trisphosphate (InsP3) and diacylglycerol [1] [2] [3] . In smooth muscle, InsP3 triggers the release of Ca2+ from intracellular stores, producing a rise in intracellular free [Ca2+] ([Ca2+]1) which activates Ca2+-calmodulin-dependent myosin light-chain kinases [4, 5] . The subsequent phosphorylation of the myosin light chain activates an actin-myosin ATPase and results in the initial phase ofmuscle contraction. The maintenance of muscle contraction (during prolonged agonist activation) is thought to involve the phosphorylation of a number of proteins (late phase) by protein kinase C, which is activated by diacylglycerol [6] .
In contrast, elevating the intracellular cyclic AMP concentration ([cAMP]1), via receptors coupled positively to adenylate cyclase (for example, histamine H2-or fi-adrenoceptors) activates cyclic AMP-dependent protein kinase A (PKA), producing smooth-muscle relaxation [5, 7] . There are a variety of possible mechanisms by which PKA is able to inhibit smooth-muscle contraction (for reviews see [4, 5, 7] ). These include: (1) the phosphorylation of myosin light-chain kinase, which decreases its affinity for the Ca2+-calmodulin complex, resulting in a decrease in myosin light-chain phosphorylation [8] ; (2) inhibition of late-phase protein phosphorylation, which may involve the cyclic AMP analogue (Sp)-adenosine 3',5'-monophosphothioate (100 ,etM). Isoprenaline (1 ,M) pretreatment (in the presence of 10 lM rolipram, a concentration which on its own did not decrease the histamine response) attenuated histamine-induced intracellular Ca2+ release. Forskolin inhibited histamine (100 ,tM)-and CPA (100 nM) stimulated accumulation of [3H]-inositol phosphates, but was without effect on ATP or bradykinin responses. Addition of forskolin (in the presence of 100 M rolipram) after the cells had been stimulated with histamine (in experiments initiated in Ca2+-free buffer) inhibited the rise in [Ca2+]i observed when extracellular Ca2`(2 mM) was re-applied (owing to receptor-mediated Ca2+ influx). Finally, the refilling of intracellular Ca2+ stores (after receptor-mediated Ca2+ influx is blocked by mepyramine) can be demonstrated in the presence of raised cyclic AMP levels.
inhibition of several kinases and/or an activation of protein phosphatase activity [6] ; (3) inhibition of receptor-mediated PtdInsP2 hydrolysis and InsP, production by phosphorylating the receptor, G-protein or phospholipase C, which has been reported in a variety of tissue and cell types, including platelets [9] , NG108-15 cells [10] and bovine tracheal [11] [12] [13] [14] and iris sphincter smooth muscle [7, 15] ; and (4) phosphorylation of the InsP3 receptor, preventing the InsP3-mediated release of intracellular Ca2+, as shown in rat brain [16] and human platelets [17] . Several effects of cyclic AMP on cellular Ca2+ metabolism have also been reported, including the inhibition of Ca2+ influx [18] , the stimulation of Ca2+ efflux [19] and increases in Ca2+ uptake into intracellular storage sites [20] . Interestingly, in bovine tracheal smooth muscle it has been found that, in the absence of muscarinic agonists, isoprenaline stimulated increases in [Ca2+] , (due to Ca2+ influx) without stimulating contraction [21, 22] .
We have previously measured [Ca2+]1 changes in response to histamine H1-and adenosine Al-receptor stimulation in monolayers of the hamster vas-deferens-derived smooth-muscle cell line DDT1MF-2 [23] [24] [25] . Activation of these receptors stimulates the release of Ca2+ from intracellular stores (InsP3-induced) and Ca2+ entry (influx) across the plasma membrane, which requires the continued presence of agonist on the receptor (receptormediated Ca2+ influx). Furthermore, the refilling of the intra- foetal-calf serum and 3 ,uM fura-2/AM and incubated for 30 min at 37 'C. After this 'loading' period, the fura-2-containing buffer was replaced with fresh buffer, which was free of fura-2 and foetal-calf serum but contained 0.1 0% BSA, and left at 37 'C for a further 15 min. Loaded coverslips were then mounted in a specifically designed holder which enabled the coverslip to be positioned across the diagonal of a polymethacrylate cuvette. Each cuvette contained 2.9 ml of physiological buffer (drugs were added to the cuvettes in 100 ,ul portions) and fluorescence measurements were made at 37 'C with a Perkin-Elmer LS 50 spectrometer. The excitation wavelengths were 340 and 380 nm, with emission at 500 nm. The slit-widths were set at 10 nm for both the excitation and emission wavelengths, and the time taken to switch between 340 and 380 nm was 0. (1) release of Ca2+ from intracellular stores, which is mediated by the second messenger InsP3 [32] ; and (2) influx of extracellular Ca2+ through Ca2+ channels in the plasma membrane [23] [24] [25] .
Figures 2(a) and 3(a) show typical responses to histamine (100 ,uM) and CPA (300 nM) respectively. These proffiles were obtained by initially stimulating the cells in nominally Ca2+-free buffer containing 0.1 mM EGTA, after which extracellular Ca2+ Table 2 ). Table 2 ). However, if the cells were preincubated for 15 min with 1 uM isoprenaline in the presence of 10 ,M rolipram, the histamine-stimulated release of intracellular Ca2+ was inhibited by 57 + 10 % (n = 7; compare Figure Sa with Figure Sb ; see Table 2 ). Figure 5( Table 2 ). Finally, the effect of a membrane-permeant analogue of cyclic AMP on histamine-stimulated increases in [Ca2+], was examined.
The cyclic AMP analogue (Rp)-cAMPS is a competitive inhibitor of PKA, whereas its diastereoisomer (S,)-cAMPS activates the kinase [33] . Pretreatment with (Sp)-cAMPS (100 ,uM, 45 min) inhibited histamine-stimulated release of intracellular Ca2l (51 + 14 % of the maximum histamine response; n = 4; P < 0.02; see Table 2 ).
Effects of cyclic AMP on the refilling of Intracellular Ca2+ stores
To evaluate the effect of raising [cAMP], on intracellular Ca2+-store refilling, experiments were performed using ATP (whose conditions, suggesting that exposure to histamine was sufficient to deplete the intracellular Ca2+ store. It should be noted in Figure 7 (a) that lO,tM mepyramine was added after the histamine response to act as an appropriate control for Figure 7 (b) and to eliminate the possibility that the loss of an ATP response was due to heterologous desensitization of ATP-mediated intracellular Ca2+ release caused by prolonged H -receptor activation. In addition, the glass coverslip was transferred to a fresh cuvette that contained Ca2+-free (plus 0.1 mM EGTA) buffer before stimulation with ATP. In Figure 7 (b) 10,tM mepyramine was added after the histamine response (to block H1-receptor-activated Ca2`influx) and followed 10 min later by a 5 min exposure to 2 mM Ca2+. As previously reported [24] in these cells, mepyramine inhibited the rise in [Ca2+1, (due to Ca2+ influx) normally observed when Ca2+ is re-applied after cells have been stimulated with histamine in nominally Ca2+-free buffer (see Figure 2a ). If the cells were then exposed to ATP (100 ,uM) in the absence of extracellular Ca2+, there was a rapid rise in [Ca23] which is attributed to release of Ca2+ from intracellular stores. Thus, as previously reported in DDT1MF-2 cells, the refilling of the internal Ca2+ store can occur in the presence of the Hantagonist mepyramine via a pathway that does not involve
[Ca2+], rising measurably above the basal level of 100 nM [24] .
Finally, to determine whether refilling of intracellular Ca2+ stores is affected by the presence of raised intracellular cyclic AMP, forskolin was added at the same time as mepyramine, i.e. 10 min before addition of extracellular Ca2+. [11] [12] [13] [14] and iris sphincter [7, 15] smooth muscle, platelets [9] , neutrophils [34] , glomerulosa cells [35] and NG108-15 cells [10] . The [10] . In contrast, data obtained with the neuroblastoma cell line NCB-20 showed that cyclic AMP elevation (by using forskolin) attenuated the duration of bradykinin-induced rises in
[Ca2+], without affecting the initial peak Ca2+ response [36] .
We also examined the effect of elevating cyclic AMP levels on agonist-induced Ca2+ influx. Histamine H1-and adenosine Areceptor-mediated Ca2+ influx were attenuated if cells were pretreated with forskolin before addition of the Ca2+-mobilizing agonist (see Figures 2 and 3) . Similar results were obtained if
[cAMP]1 levels were raised after intracellular Ca2+ stores had been released by histamine (see Figure 6 ). In contrast, ATPinduced Ca2+ influx was unaffected by forskolin (see Figure 4) . Ca2+ influx have not been elucidated. However, several postulated mechanisms have been proposed. These include the following:
(1) activation of a putative receptor-mediated Ca2+ channel by an unknown messenger that is generated as the intracellular Ca2+ stores are depleted [37] ; (2) the receptor may be directly linked to a Ca2+ channel, an example of which is the ATP-activated Ca2+ channel found in rabbit arterial smooth muscle [38] ; (3) [39] ; or (4) a G-protein-coupled Ca2+ channel. However, the mechanism(s) involved in agonist-induced Ca2+ influx in DDT1MF-2 cells and how cyclic AMP-dependent phosphorylation attenuates the Ca2+-influx response remain to be established.
We have previously reported that in DDT1MF-2 cells histamine H -receptor activation also stimulates Ca2+ influx into the intracellular Ca2+ store via a mechanism which appears independent of Hi-receptor occupancy [24] . The data presented in Figure 7 clearly showed that in the presence of raised [cAMP]1, and under conditions where receptor-activated Ca2+ influx was blocked, refilling of the intracellular Ca2+ store still occurred. In these experiments we employed ATP as the second Ca2+-mobilizing agent, since forskolin had no effect on ATP-stimulated release of intracellular Ca2 .
There have been several reports in the literature detailing the effects of cyclic AMP on cellular Ca2+ signalling. Suppattapone et al. [16] reported that cyclic AMP-dependent phosphorylation of the rat brain InsP3 receptor decreases its ability to release intracellular Ca2 . PKA activation may also block Ca2+-induced Ca2+ release [40] . Finally, McAtee and Dawson [41] proposed that PKA-mediated phosphorylation may inhibit Ca2+-induced phospholipase C activation. This would decrease inositol phospholipid hydrolysis and attenuate the duration of the Ca21 signal without affecting the initial release, as was reported for bradykinin-induced Ca2+ responses in NCB-20 cells [36] . Our previous studies [32] The mechanism(s) by which agonists activate receptor-mediated addition the membrane-permeant analogue of cyclic AMP, (Sp)-cAMPS, was also able to inhibit significantly histaminestimulated intracellular Ca2+ release. These data support the contention that cyclic AMP is the mediator involved in forskolininduced inhibition of agonist-induced inositol phosphate accumulation and intracellular Ca2+ responses.
A notable feature of the data presented in this study is the differing effects which elevating cytosolic cyclic AMP has on agonist-induced inositol phospholipid hydrolysis and intracellular Ca responses. The reasons for the selective inhibition of histamine H1-and adenosine A1-receptor-mediated responses, as opposed to the bradykinin-or ATP-induced responses, which are unaffected, are unclear. One possibility is that the proteins involved in the signal-transduction pathways associated with bradykinin or ATP-receptor activation are not suitable substrates for PKA phosphorylation. A similar discriminative effect of cyclic AMP on histamine Hl-receptor-mediated, but not muscarinic receptor-mediated, inositol phospholipid hydrolysis has been reported in airway smooth muscle [11] .
In summary, the present study has shown that elevating We thank the Wellcome Trust for financial support.
